by ADRIAN FREDERICK MANZ Manz | Aug 12, 2025 | The Doctor's Dose
Housing Market Correction Indicators: 3 Key Trends to Watch Despite appearing stagnant on the surface, the U.S. housing market is showing early signs of a potential shift—and possibly a correction. Economists are closely monitoring several key indicators to assess...
by ADRIAN FREDERICK MANZ Manz | Aug 11, 2025 | The Doctor's Dose
Uber’s Autonomous Ambitions Spark Tesla Volatility: What Traders Need to Watch Shares of Uber Technologies (UBER) climbed in early trading Wednesday after the company posted strong second-quarter earnings, beat across key metrics, and unveiled a $20 billion share...
by ADRIAN FREDERICK MANZ Manz | Aug 10, 2025 | The Doctor's Dose
Pfizer Raises Guidance Amid Drug Pricing Pressure: What Traders Should Know Pfizer (PFE) raised its full-year earnings guidance this week, signaling early success in its multibillion-dollar cost-cutting strategy while navigating political pressure from President...
by ADRIAN FREDERICK MANZ Manz | Aug 9, 2025 | The Doctor's Dose
Teradyne Leads the S&P 500 After Strong Earnings and AI Momentum Teradyne (TER) shares surged Wednesday, topping the S&P 500 leaderboard after the company delivered solid second-quarter results and projected accelerating growth tied to artificial intelligence...
by ADRIAN FREDERICK MANZ Manz | Aug 9, 2025 | The Doctor's Dose
Super Micro (SMCI) Slashes Guidance—And Still Misses the Mark for Wall Street Shares of Super Micro Computer Inc. (SMCI) plunged over 17% in premarket trading Wednesday after the company lowered its full-year revenue forecast and offered little reassurance on margins,...
by ADRIAN FREDERICK MANZ Manz | Aug 8, 2025 | The Doctor's Dose
Ford tariff impact 2025 Ford Motor Co. is feeling the sting of rising trade tensions. On Wednesday, the automaker warned investors that tariff-related costs are now expected to total $2 billion in 2025—a $500 million increase from its previous estimate in May. While...
by ADRIAN FREDERICK MANZ Manz | Aug 8, 2025 | The Doctor's Dose
Trade Truce or Powder Keg? Trump’s EU Deal Leaves Markets Guessing In a week already brimming with geopolitical uncertainty, a fragile U.S.–EU trade agreement has injected fresh volatility into global markets. European Union officials announced that they would suspend...
by ADRIAN FREDERICK MANZ Manz | Aug 8, 2025 | The Doctor's Dose
Intel CEO Lip-Bu Tan Faces Internal Rift, Political Pressure, and Strategic Crossroads Intel’s new CEO, Lip-Bu Tan, has been in the job for just a few months, but already finds himself at the center of a high-stakes battle — one that spans boardroom disputes,...
by ADRIAN FREDERICK MANZ Manz | Aug 7, 2025 | The Doctor's Dose
A new chapter in U.S. freight transport is unfolding under the stars. Autonomous trucks are now running overnight routes on some of Texas’s busiest highways, thanks to Aurora Innovation, a company pushing the boundaries of self-driving technology. The company’s...
by ADRIAN FREDERICK MANZ Manz | Aug 7, 2025 | The Doctor's Dose
Higher Tariffs Are Here to Stay: What Traders Need to Know Now As of August 7, tariffs on dozens of countries are officially in effect, signaling a major shift in U.S. trade policy. The Trump administration’s strategy is clear: higher tariffs are here to stay, and...
